This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Effects of an Auto-Regulating Oxygen System Compared to Constant-Flow Oxygen During Walking in Hypoxemic COPD Patients

Sponsored by Schön Klinik Berchtesgadener Land

About this trial

Last updated 6 years ago

Study ID

COPD FreeO2-Study

Status

Completed

Type

Interventional

Phase

N/A

Placebo

No

Accepting

18-75 Years
40 to 80 Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Ended 6 years ago

What is this trial about?

Oxygen therapy is a cornerstone in treating patients with severe chronic obstructive pulmonary disease. Usually, oxygen supplementation is delivered using constant-flow rates. Varying oxygenation levels may occur throughout patients´ changing activity. There is some evidence available that an auto-regulating oxygen flow system (FreeO2), which adjusts the oxygen flow automatically to prevent desoxygenation could be beneficial in comparison to a constant oxygen dose of 2 liter/min during walking. However, these possible benefits are unknown if the FreeO2 is compared to a constant oxygen dose according to the individual prescription. Therefore, the primary aim of this study is to investigate the effects of auto-regulated oxygen flow rates compared to constant oxygen flow rates as prescribed according to international guidelines on walking capacity in patients with COPD.

What are the participation requirements?

Yes

Inclusion Criteria

- GOLD III/ IV

- Hypoxemia (PaO2<55 mmHg) under roomair conditions (rest or during exercise) or SpO2 <88% during exercise

- established Long-term oxygen therapy or given indication for a Long-term oxygen therapy

- Age: 40 to 80 years

- Participation in an inpatient pulmonary rehabilitation program (Schoen Klinik BGL, Germany)

- Written informed consent

No

Exclusion Criteria

- Acute Exacerbation of COPD

- Clinical signs of any acute cardiac comorbidity

- Not able to walk